All News

ViewPoints: Magenta looks to show off the true colours of its transplant pipeline

Ref: ViewPoints Desk

Tags: ViewPoints Magenta Therapeutics Clinical Research (R&D)MGTA-145 MGTA-456

ViewPoints: Eisai lays out case for BAN2401

Ref: ViewPoints Desk

Tags: ViewPoints Eisai Biogen Dementia FDA Clinical Research (R&D)BAN2401

ViewPoints: Key takeaways from Biogen’s Q1 earnings and investor call

Ref: ViewPoints Desk

Tags: ViewPoints Biogen Eisai Ionis Pharmaceuticals Multiple Sclerosis FDA Corporate Affairs Marketing & Sales Medical Affairs Spinraza Tecfidera BAN2401 Vumerity BIIB092 BIIB059

Ascendis Pharma A/S Announces Presentations Related to Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences

Ref: GlobeNewswire

Tags: Press Release Ascendis Pharma Clinical Research (R&D) Medical Affairs TransCon hGH TransCon PTH

GeNeuro: Financial Information and Business Update for the First Quarter 2019

Ref: Business Wire

Tags: Press Release GeNeuro Corporate Affairs

GenSight Biologics Reports Full Year 2018 Financial Results

Ref: Business Wire

Tags: Press Release GenSight Biologics Corporate Affairs

Mallinckrodt Completes Expansion of Operations and Manufacturing Facility for StrataGraft Regenerative Skin Tissue in Madison, Wis.

Ref: PR Newswire

Tags: Press Release Mallinckrodt Burns Corporate Affairs StrataGraft

B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with attached safety needle

Ref: GlobeNewswire

Tags: Press Release B. Braun Thrombosis Marketing & Sales heparin

Feraccru granted major extension to approval in Switzerland

Ref: Shield Therapeutics

Tags: Press Release Shield Therapeutics Anaemia Swissmedic Marketing & Sales Regulatory Affairs Ferracru

Alkindi granted Orphan Drug Designation in Australia and grant of second Alkindi patent in Australia

Ref: Diurnal

Tags: Press Release Diurnal TGA Corporate Affairs Regulatory Affairs Alkindi